Marchingo A J, Abrahams J M, Woodcock E A, Smith A I, Mendelsohn F A, Johnston C I
Department of Medicine, Monash University, Melbourne, Victoria, Australia.
Endocrinology. 1988 Apr;122(4):1328-36. doi: 10.1210/endo-122-4-1328.
[3H]1-Desamino-8-D-arginine vasopressin [3H] DDAVP was assessed as a radioligand for vasopressin V2-receptors by studying its membrane-binding characteristics and in vitro autoradiographic localization in rat kidney, a rich source of V2-receptors. [3H]DDAVP bound specifically to a single class of high affinity, low capacity sites in rat medullopapillary membranes. Specific [3H]DDAVP binding at 25 C reached equilibrium after 2 h of incubation and was saturable and linear with protein concentration up to 2.2 mg/ml protein. Saturation analysis gave an equilibrium dissociation constant (Kd) of 0.76 nM. Displacement of [3H]DDAVP binding by unlabeled arginine vasopressin (AVP) and related analogs gave the following order of potency, consistent with that expected for a V2-receptor: DDAVP approximately equal to AVP approximately equal to 1-desamino-AVP greater than lysine vasopressin greater than oxytocin greater than [1-(beta-mercapto-beta, beta-cyclopentamethylene-propionic acid, 2-(O-methyl)tyrosine]AVP. The C-terminal metabolites of AVP, (pGlu4Cyt6)AVP-(4-9), and (pGlu4Cyt6)AVP-(4-8) did not displace [3H]DDAVP binding. No degradation of [3H] DDAVP during incubation could be detected by HPLC analysis. In vitro autoradiography of [3H]DDAVP binding to rat kidney sections showed a very dense localization of displaceable binding over inner and outer medulla, with a much lower density in cortex, consistent with the known major localization of V2-receptors on renal collecting tubules. These studies suggest that [3H]DDAVP is a suitable radioligand for labeling V2-receptors and may be useful in the characterization of vasopressin receptor subtypes in a variety of tissues and in purification of the V2-receptor.
通过研究[3H]1-去氨基-8-D-精氨酸加压素([3H]DDAVP)的膜结合特性以及在大鼠肾脏(V2受体的丰富来源)中的体外放射自显影定位,评估其作为加压素V2受体的放射性配体。[3H]DDAVP特异性结合大鼠髓质乳头膜中的一类单一的高亲和力、低容量位点。在25℃下,[3H]DDAVP的特异性结合在孵育2小时后达到平衡,并且在蛋白质浓度高达2.2mg/ml时是可饱和的且与蛋白质浓度呈线性关系。饱和分析得出平衡解离常数(Kd)为0.76nM。未标记的精氨酸加压素(AVP)及相关类似物对[3H]DDAVP结合的置换给出了以下效价顺序,与V2受体预期的顺序一致:DDAVP≈AVP≈1-去氨基-AVP>赖氨酸加压素>催产素>[1-(β-巯基-β,β-环戊亚甲基丙酸,2-(O-甲基)酪氨酸]AVP。AVP的C末端代谢产物(pGlu4Cyt6)AVP-(4-9)和(pGlu4Cyt6)AVP-(4-8)不能置换[3H]DDAVP的结合。通过高效液相色谱分析未检测到孵育过程中[3H]DDAVP的降解。[3H]DDAVP与大鼠肾脏切片结合的体外放射自显影显示,在内髓和外髓有非常密集的可置换结合定位,皮质中的密度要低得多,这与V2受体在肾集合管上已知的主要定位一致。这些研究表明,[3H]DDAVP是用于标记V2受体的合适放射性配体,可能有助于表征多种组织中的加压素受体亚型以及纯化V2受体。